BioPharma Resources

Drug Trial Radar · NCT07796191

Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects

A Clinical Trial of Drug-drug Interactions for VC005 Tablets in Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Sep 20, 2026

Primary completion

Nov 30, 2026

Study completion Nov 30, 2026

Sponsor

Sponsor type
Industry
First posted
Sep 1, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study includes three groups of Drug-Drug Interaction( DDI ) studies: 1. To evaluate the effect of verapamil on the pharmacokinetics of a single oral dose of VC005 in healthy subjects; 2. To evaluate the effect of probenecid on the pharmacokinetics of a single oral dose of VC005 in healthy subjects; 3. To evaluate the effect of VC005 on the pharmacokinetics of a single oral dose of metformin tablets in healthy subjects.

Conditions

  • Healthy Adult Participants

Interventions

  • VC005 and verapamilDrug

    A single dose of VC005 was administered in the period 1. and a single dose of VC005 and verapamil coadministration in the period 2.

  • VC005 and probenecidDrug

    A single dose of VC005 was administered in the period 1. and a single dose of VC005 and probenecid coadministration in the period 2.

  • VC005 and metforminDrug

    A single dose of metformin was administered in the period 1. and a single dose of metformin and VC005 coadministration in the period 2

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Observed Plasma Concentration (Cmax)Time frame: Day1-Day12
  2. Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUC)Time frame: Day1-Day12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Zhongda Hospital,Affiliated to Southeast University

    Nanjing, Jiangsu, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.